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OBJECTIVES: Brief, reliable, and valid self-administered
questionnaires could facilitate the diagnosis of gastroesoph-
ageal reflux disease in primary care. We report the devel-
opment and validation of such an instrument.
METHODS: Content validity was informed by literature re-
view, expert opinion, and cognitive interviewing of 50 pa-
tients resulting in a 22-item survey. For psychometric anal-
yses, primary care patients completed the new questionnaire
at enrollment and at intervals ranging from 3 days to 3 wk.
Multitrait scaling, test–retest reliability, and responsiveness
were assessed. Predictive validity analyses of all scales and
items used specialty physician diagnosis as the “gold stan-
dard.”
RESULTS: Iterative factor analyses yielded three scales of
four items each including heartburn, acid regurgitation, and
dyspepsia. Multitrait scaling criteria including internal con-
sistency, item interval consistency, and item discrimination
were 100% satisfied. Test–retest reliability was high in those
reporting stable symptoms. Scale scores significantly
changed in those reporting a global change. Regressing
specialty physician diagnosis on the three scales revealed
significant effects for two scales (heartburn and regurgi-
tation). Combining the two significant scales enhanced
the strength of the model. Symptom response to self-
directed treatment with nonprescription antisecretory
medications was highly predictive of the diagnosis also,
although the item demonstrated poor validity and reli-
ability.
CONCLUSIONS: A brief, simple 12-item questionnaire dem-
onstrated validity and reliability and seemed to be respon-
sive to change for reflux and dyspeptic symptoms. (Am J
Gastroenterol 2001;96:52–57. © 2001 by Am. Coll. of Gas-
troenterology)
INTRODUCTION
Recent research on diagnostic methodology for gastro-
esophageal reflux disease (GERD) has provided two impor-
tant observations. First, most individuals seen by primary
care physicians for GERD do not have significant esoph-
agitis (1). Second, it has been recognized that there is not a
criterion standard for diagnosis of the illness (2, 3). Al-
though initially proposed as a “gold standard” for the diag-
nosis of GERD, 24-h ambulatory pH monitoring is not
sufficiently sensitive to serve as a criterion standard (2,
4). Recent evidence has suggested that a brief treatment
trial with a proton pump inhibitor may be the most
sensitive and specific diagnostic modality (2, 5). How-
ever, studies of that potential diagnostic test have some
limitations, including the fact that the survey instrument
supporting the test has not been validated for the diag-
nosis of GERD.
A number of surveys that include items pertinent to
GERD have been developed and published in the past 5 yr
(6–11). Five of these surveys are of established reliability
and validity for assessment of symptom severity (6–10) and
health-related quality of life (6–9). Three have been shown
to be sensitive to change with treatment of GERD (7, 8, 12).
None has been evaluated for discriminant (diagnostic) va-
lidity for GERD, although all would be good candidates for
such studies.
Discriminant validity has been briefly examined in one of
these surveys (11). Cognitive interviewing or focus group
testing of patients was not included in the initial design of
that instrument, and the study population was highly en-
riched for reflux disease. Scale scores were not generated
with simple addition, but required differential weighting of
various items. Empiric support for the selected item weights
was not provided. An important contribution of that study
was recognition that the word “heartburn” is less sensitive
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than a word picture of the symptom (“a burning feeling
rising from your stomach or lower chest up toward your
neck”) (11).
The Digestive Health Status Instrument (DHSI) GERD/
Ulcer scale has been compared to 24-h ambulatory pH
monitoring in a population of referral patients, and the scale
scores correlated highly with acid contact time (12). The
DHSI is relatively long at 34 questions, limiting routine
application in a primary care setting.
We report the development and validation of a brief
instrument for the diagnosis of GERD that is simple to
administer, to score, and to interpret.
MATERIALS AND METHODS
Setting
From July 14, 1999 to September 17, 1999, two separate
subject groups were enlisted: one to participate in question-
naire development and the other in questionnaire validation.
Adults aged$18 yr were recruited from various primary
care clinics of Park Nicollet Clinic, HealthSystem Minne-
sota, Minneapolis, MN. Park Nicollet is a 500 physician
multispecialty group serving the western and southern sub-
urbs of Minneapolis, MN.
Survey Development
Content validity of the survey was established following the
method of Dillman (13). The literature was searched for
survey instruments and the pertinent ones were carefully
reviewed (6–11). The questionnaire was drafted by the
principal investigator and a survey methodologist on the
research team. The core elements of this first questionnaire
possessed many similarities to the Carlsson-Dent reflux
scale (11). The survey content and wording were modified
by the other members of the research team. The questions
were scaled.
Cognitive interviews on the content and wording of the
new survey using a planned script were conducted in 25
patients presenting to discuss reflux symptoms with their
primary care physician. Patients received a $25 honorarium
for their participation. Patients were interviewed by a survey
technician after they had completed both questionnaires.
Subjects were queried as to whether the items adequately
surveyed the breadth of their symptoms. Potential problems
with the design or wording of questions and interpretation
were sought.
Results of the cognitive interviewing were presented at a
meeting of all coinvestigators. Changes informed by the
cognitive interviewing were incorporated into the question-
naire to improve clarity.
The reworded questionnaire was presented to 10 of these
25 subjects in two focus group sessions for review. No
additional revisions were suggested. Cognitive interviews as
described above were conducted in a different group of 25
patients. No additional changes were suggested.
Survey Validation
For the validation of the new survey, 200 consecutive Park
Nicollet Clinic primary care patients from nine separate
clinic sites in the southern and western suburbs of Minne-
apolis, MN, were recruited. All had appointments with their
family practice or internal medicine physician to discuss
upper abdominal complaints that might include but did not
require the presence of reflux symptoms. Eligible patients
were identified by a three-item questionnaire at registration
asking whether the patient was visiting the healthcare pro-
vider to discuss upper abdominal pain or heartburn, whether
he or she had taken prescription medication for symptoms in
the past month, and general interest in completing a short
survey. Those who had received prescription medication in
the month preceding entry were excluded. Subjects who
completed the survey on two occasions and a specialty
physician interview received a $50 honorarium. The survey
included the 22-item pilot version of the Reflux Disease
Diagnostic Questionnaire (RDQ) and the Digestive Health
Status Instrument (DHSI). Each of these measures is de-
scribed in more detail in the following sections. Surveys
were completed and returned. To determine whether they
had GERD, subjects were interviewed by a board-certified
gastroenterologist. Power calculations revealed a need for
150 subjects. These 150 subjects were randomly selected
from the pool of 200 to ensure that there were no differences
in age and gender of the smaller subset compared to the
complete study population.
MEASURES. The new instrument, in its pilot form, had 22
items. The time referent used was symptoms over the last 4
wk. Item content included the following: 1) 12 questions on
the frequency, severity, and duration of burning and pain
behind breastbone, acid taste in mouth, movement of ma-
terials upward from the stomach, and burning and pain in
the upper stomach; 2) one question asking for the location
where symptoms were most severe; 3) two questions on
whether symptoms were caused or worsened by eating,
lying flat, or bending over; 4) two questions on relief of
symptoms by indigestion medications or eating; 5) three
questions on the interference of symptoms in patients’ sleep,
work, and enjoyment of life; and 6) one question asking
which symptom caused the greatest interference with life.
Most response options were scaled as closed-ended and
Likert-type, with categories ranging from 1 to 5 or with 1–7
points for frequency, severity, and duration of symptoms.
The item assessing the area affected contained a diagram of
a human torso, and the patient was asked to mark the area
most affected.
The DHSI is a 34-item, disease-specific instrument with
demonstrated reliability and validity (6). Five separate con-
structs measured by the DHSI include GERD/Ulcer, dys-
motility, a two-domain bowel dysfunction complex, and a
pain index. The psychometric properties of these five sum-
mated disease-specific scales compared favorably with stan-
dardized health status measures. As was the case with the
53AJG – January, 2001 Validation of Diagnostic Questionnaire for GERD
RDQ, the time referent of the DHSI is symptom occurrence
over the last 4 wk and response scales are Likert-type and
closed-ended with values ranging usually from 1 to 6.
RESPONSIVENESS QUESTIONS. To assess the respon-
siveness of the RDQ, patients were asked to rate their upper
abdominal symptoms since their last visit on a three-point
scale including better, unchanged, and worse. If their symp-
toms had changed, patients were asked to rate how much
they had changed on a seven-point scale ranging from
changed hardly at all to changed a great deal. This has been
referred to as the observed treatment effect (OTE) (14). The
patient’s physician was unaware of participation in the
study, and patient management was provided at the discre-
tion of the individual physician. Many patients received
antiscretory therapy at the enrollment visit.
SPECIALTY PHYSICIAN DIAGNOSIS. A random selec-
tion of 75% of the study population was interviewed by a
gastroenterologist to determine if GERD was present. Six
board-certified gastroenterologists participated in the inter-
viewing. The physicians were aware that the study objective
was to develop a brief reflux disease survey but did not have
knowledge of the questionnaire content or wording, the
study protocol, or the individual subject responses to the
questionnaire. Interrater reliability of the group of physi-
cians was determined before the subjects were interviewed.
Ten cases of established diagnoses including GERD alone
(4), irritable bowel syndrome (IBS) alone (3), and GERD-
IBS (3) were identified from the records of Park Nicollet
Clinic. Five actors were trained to present two cases each
and were interviewed individually by the six physicians.
Physicians were asked to decide whether the patient had
GERD, IBS, or neither and to provide certainty of the
diagnosis. Agreement on diagnosis from interviews of the
10 cases was determined andk calculated (15). Thek levels
reached acceptable levels for the diagnosis of GERD (0.90)
and IBS (0.80).
Psychometric Evaluation
There were three primary objectives in the psychometric
evaluation of the RDQ: 1) item reduction and scale devel-
opment; 2) convergent and predictive validity assessment;
and 3) stability and responsiveness assessment. Item reduc-
tion and scale development employed approaches associated
with multitrait scaling, including item–response variability,
factor analytic testing, scale internal consistency, item con-
vergent validity, item discrimination validity, and item–total
correlations (16). Convergent validity assessment looked at
correlations between RDQ scales and those contained in the
DHSI. Similar comparisons of the RDQ scales with spe-
cialty physician diagnosis were conducted to assess the
predictive validity of the RDQ. The predictive capability of
individual questions was also assessed. The stability of the
RDQ scales was examined by test–retest reliability through
construction of intraclass correlation coefficients in those
reporting no change in symptoms, and responsiveness was
determined in those reporting at least moderate change
using thet statistic for paired samples. Assignment to an
unchanged or improved group was based on response to the
observed treatment effect question (14).
RESULTS
For the instrument validation, a total of 200 patients meeting
the inclusion criteria were enrolled in the study. Of these,
176 (88%) patients filled out the initial packet of surveys
that included the RDQ and the DHSI. The participant pool
included 123 (70%) women and 53 (30%) men. The mean
age of responders was 50.5 yr. One respondent was an
African-American woman and another an Asian man; all
other study participants were Caucasian. A total of 150 of
these respondents were interviewed by a specialty physi-
cian; 92% of those interviewed completed the questionnaire
a second time at intervals of 3 days to 3 wk. Physician
diagnoses were GERD in 69%, IBS in 37%, GERD and IBS
in 17%, and neither in 17%.
Content Validity
Additional content was not suggested by any of the 50
persons in the questionnaire development cohort; however,
consistent themes emerged from the cognitive interviewing,
indicating a need for significant rewording of the questions.
The first was the challenge for patients in responding to
questions requiring integration of more than two pieces of
information in one question,e.g., asking for the quality
(“burning”), location (“stomach or lower chest”), and move-
ment of a symptom (“rising”) in one question. The second
concerned describing reflux symptoms as “rising upward.”
Only 20% of those interviewed with GERD reported up-
ward movement, and patients were as likely to report down-
ward or a posterior movement to their reflux symptoms. The
percentage of subjects without GERD reporting upward
movement of their symptoms nearly equaled that found in
those with GERD (15%vs20%, respectively). Selection of
location was problematic; 80% specified that separating
symptom location in the upper stomach from lower chest
was preferred over combining into one question. These
observations were incorporated into the pilot questionnaire
after review by the entire group of coinvestigators.
Item Reduction and Scale Development
ITEM REDUCTION. A total of 10 items were deleted from
the original 22-item pilot RDQ. Two items measuring relief
of symptoms by eating and symptoms that caused the great-
est interference with life were discarded because they failed
to meet the item-response criterion requiring that response
distributions and standard deviations be roughly symmetri-
cal in items measuring the same construct. Four more items
were deleted because they failed to meet the factor analytic
interpretability criteria requiring item loadings of.0.4 on
only one component for an item to be retained. The items
included areas most affected by symptoms, symptoms
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caused or made worse by eating, relief of symptoms through
use of indigestion medications, and symptoms caused or
made worse by lying flat or bending over. Finally, the item
measuring duration of symptoms and the three items mea-
suring symptom interference with sleep, work, and life
enjoyment (quality of life) were discarded because of their
questionable ability to forecast specialty physician diagnosis
at the item level (the scale–level predictive validity assess-
ment described in detail below).
SCALE DEVELOPMENT. To examine the dimensionality
of the remaining 12 items, principal component analysis was
repeated. From one to four component models were consid-
ered. A three-factor solution was considered most plausible
and is shown in Table 1.
The first component contains four items that were thought
to measure the domain of “regurgitation.” Constituent items
address the frequency and severity of acid taste and move-
ment of materials. The second four-item component, labeled
“heartburn,” is composed of items measuring frequency and
severity of burning and pain behind the breastbone. The
final component measures dyspeptic symptoms. Constituent
items include upper stomach pain severity, upper stomach
pain frequency, upper stomach burning frequency, and up-
per stomach burning severity.
Cronbach’sa was calculated to demonstrate the cohe-
siveness of items in each extracted component (17). All
three components demonstrated high internal consistency,
with a scores exceeding the acceptable level of 0.70 (see
Table 1) (18).
Item–scale correlations were examined in a matrix in
which the items are in rows and the scales are in columns.
Correlations between items and scales were corrected for
overlap. Analyses of these correlations, which are them-
selves a measure of item convergent validity, showed that
each item had a correlation with its relevant scale of$0.40
(data not shown). Similarly, the item discrimination crite-
rion (discriminant validity) requiring that the correlation
between an item and its hypothesized scale be greater than
two standard errors (SE) larger than any other correlation in
the same row to consider it a scaling success was also
satisfied (data not shown).
The last component of multitrait scaling, the assessment
of item–total correlations, requires that items in the same
scale contain the same proportion of information about the
construct. The range of correlations corrected for overlap for
each scale was examined. Items identified in the principal
component analysis to belong to a scale correlated most
closely with the hypothesized scale for every single item.
Regurgitation correlations ranged from 0.66–0.76, heart-
burn 0.61–0.70, and dyspepsia 0.58–0.65.
Multitrait scaling criteria were 100% satisfied by the three
scales, justifying the simple addition of subject responses to
obtain scale scores.
Convergent and Predictive Validity Assessment
This step attempted to assess the convergent validity of the
RDQ by looking at how well the identified scales of the
RDQ correlated with another scale that is believed to mea-
sure the same construct: the GERD/Ulcer scale of the DHSI.
Evidence for the predictive validity of the RDQ (meaning
how well it forecasts specialty physician diagnosis) was also
sought in this step.
CONVERGENT VALIDITY. The extent to which the
identified scales correlated with the DHSI scales was as-
sessed by calculating Pearson product-moment coefficients.
We hypothesized that the GERD/Ulcer scale of the DHSI
would correlate highly with the heartburn and regurgitation
scales of the new survey. Table 2 shows that the highest
correlation was observed for the relationship between the
RDQ heartburn and DHSI GERD/Ulcer scales (0.52).
Table 1. Results of the Principal Component Analysis and Internal Consistency Reliability Analysis
BreDQ Question Regurgitation GERD Dyspepsia
2c. Acid taste severity 0.89796 20.10826 20.02118
2d. Movement of materials severity 0.83424 0.00360 20.00187
1c. Acid taste frequency 0.79231 0.00545 0.07755
1d. Movement of materials frequency 0.77503 0.03962 0.02054
1a. Frequency of burning behind breastbone 0.02244 0.88609 20.15100
2a. Severity of burning behind breastbone 0.12303 0.87884 20.18781
1b. Frequency of pain behind breastbone 20.14538 0.71539 0.34627
2b. Severity of pain behind breastbone 20.11166 0.65196 0.27500
2f. Upper stomach pain severity 20.02989 20.10742 0.93534
1f. Upper stomach pain frequency 20.01706 20.04117 0.92785
1e. Upper stomach burning frequency 0.26315 0.24351 0.47527
2e. Upper stomach burning severity 0.32110 0.16140 0.45311
Cronbach’sa 0.85 0.81 0.80
GERD 5 gastroesophageal reflux disease.




Heartburn1 ulcer 0.42 0.52 0.30
Pain experience 0.17 0.33 0.47
DHSI 5 Digestive Health Status Instrument.
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PREDICTIVE VALIDITY. Table 3 provides the mean scores
for each of the three RDQ scales in those with and without
GERD by physician diagnosis; the significance of the scale’s
ability to predict specialty physician diagnosis of GERD; and
the c-statistic, a measure of the scale’s ability to discriminate
between those meeting the diagnostic threshold and those who
do not. Both the heartburn and regurgitation scales significantly
predicted physician diagnosis at thep 5 0.01 level. The dys-
pepsia scale failed to provide any evidence of predictive power.
The c-statistic showed moderate accuracy (0.64) of the heart-
burn and regurgitation scales in classifying patients into one of
the two diagnostic categories.
The strongest predictor of physician diagnosis was re-
sponse of symptoms to various over-the-counter medica-
tions (p 5 0.0076, with c-statistic of 0.70).
Stability and Responsiveness
TEST–RETEST RELIABILITY. In all, 58 subjects re-
ported no change in symptoms 3 days to 3 wk after entry on
the observed treatment effect question (17). Intraclass cor-
relation coefficients were calculated from the questionnaires
of those who reported no change in symptoms over the
period of observation. All three RDQ scales demonstrated
reliability coefficients ranging from 0.8 to 0.88 well beyond
the acceptable level of 0.70 (data not shown) (18).
RESPONSIVENESS. Responsiveness was determined in
the subset of 59 respondents who indicated at least moderate
change on the observed treatment effect. The Student’st test
for paired samples was calculated comparing those who
remained stable to those reporting at least moderate change.
The p values were#0.0029 for all three scales, providing
strong evidence for the responsiveness of each of the three
scales of the RDQ (data not shown).
DISCUSSION
Progress in studying the medical and financial impact of gas-
troesophageal reflux disease (GERD) is compromised by the
lack of patient-report questionnaires validated for the diagnosis
of GERD. Methodological (e.g., limited psychometric evalua-
tion) and administrative (e.g., length) shortcomings associated
with earlier attempts to develop such instruments limit the
potential application of these instruments. The purpose of this
investigation was to develop a reliable and valid instrument for
the diagnosis of GERD that could be easily administered by
primary care physicians in community settings.
Developing a questionnaire with excellent content validity
requires careful attention to both question content and clarity of
wording. No amount of sophisticated psychometrics can com-
pensate for deficiencies in what—and how—questions are
asked. Question selection and wording were informed by a
review of the literature, input from a number of investigators
who have developed and validated GI symptom question-
naires, and, most importantly, detailed cognitive interviewing
of patients. Despite the prior development of many reflux
questionnaires (6–12), cognitive interviewing demonstrated
that the wording of some questions in these questionnaires
created interpretation difficulties for patients, highlighting the
need for focus group testing or cognitive interviewing during
the development of any new surveys.
Scale development provided empirical support for three
distinct symptom profiles: heartburn, regurgitation, and dys-
pepsia. Item reduction efforts nearly halved the number of
items in the survey. Scale reliability was demonstrated by the
high levels of internal consistency. Strong support for other
elements of multitrait scaling including item–scale correla-
tions, item discrimination, and item–total correlations was ob-
served. Complete satisfaction of multitrait scaling criteria jus-
tifies combining the items into scales that can be scored with
simple addition, thus eliminating the need for item weighting.
The high correlations between the GERD/Ulcer scale of
the Digestive Health Status Instrument (DHSI) and the
heartburn scale of the RDQ attest to the convergent validity
of the RDQ. The ability of the heartburn and regurgitation
scales to predict specialty physician diagnosis demonstrates
the predictive validity of at least two of the three scales of
the RDQ; the dyspepsia scale failed to demonstrate accept-
able predictive validity. The lack of predictive validity of
the dyspepsia scale and the principal component analyses
demonstrating that symptoms in the upper stomach are a
distinct construct from those located in the retrosternal area
validates the results of the cognitive interviewing, leading to
a decision to include symptom locations.
The dyspepsia scale demonstrated excellent internal va-
lidity and was responsive to change. Its psychometric
strength combined with information that primary care and
community populations frequently demonstrate overlapping
symptom complexes, including elements of reflux and dys-
pepsia (19), support retaining the dyspepsia scale pending
future research using this instrument. The scales proposed
for GERD diagnosis, however, are limited to the regurgita-
tion and heartburn scales.
A gold standard for the diagnosis of GERD does not exist.
The sensitivity of endoscopy is limited, as most patients
with GERD do not have mucosal injury (1). Ambulatory pH
monitoring also has problems with sensitivity, given the
intermittent nature of symptoms and the disturbance of
routine daily activities by placement of a pH probe (2–4).
Specialty physician diagnosis is an acceptable gold standard
in the absence of a definitive objective test (20, 21). The six
Table 3. Predictive Validity: Logistic Regression of BreDQ
Scale Scores on Specialty Physician Diagnosis
Scale
Physician Diagnosis





Heartburn 8.7 (5.2) 6.2 (5.4) 0.01 0.64
Regurgitation 6.6 (5.0) 4.3 (4.1) 0.01 0.64
Dyspepsia 7.1 (5.1) 7.7 (5.3) 0.55 0.53
OTC response 3.2 (2.3) 2.3 (0.9) 0.0076 0.70
* Based on logistic regression analysis.
GERD 5 gastroesophageal reflux disease; OTC5 over-the-counter medication.
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gastroenterologists demonstrated excellent agreement, both
among themselves and on patient diagnosis, when inter-
viewing actors presenting cases of established diagnoses,
thus supporting the use of specialty physician diagnosis as a
gold standard. High correlations between the GERD/Ulcer
scale of the DHSI and the RDQ provide indirect support for
the validity of this approach given the established correla-
tion of the GERD/Ulcer scale of the DHSI with ambulatory
pH monitoring in GERD patients (12).
One intriguing finding was that the strongest predictor of
specialty physician diagnosis was the question on the re-
sponse of symptoms to self-directed, over-the-counter med-
ications. The predictive power of this single question sur-
passed that of any of the three scales alone, any combination
of the three scales, or the other 20 individual items in the
questionnaire (data not shown). Despite this, however, the
question demonstrated poor internal validity as well as in-
ternal consistency below an acceptable level, resulting in its
deletion from the final survey. The work of Fasset al. and
of others suggests that a more structured approach to as-
sessing response maybe the preferred diagnostic method for
GERD (2, 4). The studies of diagnostic treatment trials have
possessed a number of methodological shortcomings, how-
ever, including the lack of valid and reliable surveys to
assess treatment effect. A diagnostic trial using the RDQ to
assess response to standardized treatment with superior acid
suppression would retain the observed predictive strength of
the response to OTC medications, but without compromis-
ing validity and reliability.
Although these results are encouraging, readers should be
mindful of some study limitations. The stability and respon-
siveness of the instrument was examined in a minority of the
research subjects for whom treatment was directed by indi-
vidual physicians and not by study design. Generalization of
results from a study performed in only one location among
a Caucasian population to other areas with different racial/
ethinic populations cannot be assumed. Although there is
precedent for using specialty physician diagnosis as a gold
standard for disease diagnosis, this approach has not been
definitively validated for GERD. Studies addressing these
limitations are underway, including the use of question-
naires in other countries besides the United States and in
other languages in addition to English.
A brief survey for the diagnosis of GERD in primary care
and community settings that can be simply administered and
scored has been developed and validated. The identified
predictive strength of response to treatment argues in sup-
port of a diagnostic treatment trial. The discriminative (di-
agnostic) validity of the heartburn and regurgitation scales
will be definitively established in such a study.
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